Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients

被引:8
|
作者
Zhang, Ziyin [1 ,2 ]
Zhang, Lu [1 ,2 ]
Jiang, Wangyan [1 ,2 ]
Du, Tingting [1 ,2 ]
Yuan, Gang [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Endocrinol, Wuhan 430030, Peoples R China
[2] Branch Natl Clin Res Ctr Metab Dis, Wuhan, Peoples R China
关键词
Non-obese non-alcoholic fatty liver disease; Cardio-metabolic risk; Type 2 diabetes mellitus; FATTY LIVER-DISEASE; PREVALENCE; ASSOCIATION;
D O I
10.1186/s12933-022-01648-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Non-obese non-alcoholic fatty liver disease (NAFLD) has been reported to share clinical outcomes with its obese counterpart in the general population. However, conflicting results have been observed regarding the cardio-metabolic risk profile of non-obese NAFLD as compared to obese NAFLD. Moreover, in the context of type 2 diabetes mellitus (T2DM), this issue has been even less addressed. We hence aimed to examine the association of NAFLD with the cardio-metabolic risk profile in patients with T2DM according to their obesity status. Methods A total of 2,708 patients with T2DM who were hospitalized between June 2018 and May 2021 were cross-sectionally assessed. Results The prevalence of NAFLD was 49.3%. NAFLD was found in 34.1% of non-obese patients and 66.0% of obese patients. Non-obese NAFLD patients had more and worse metabolic disorders than obese patients without NAFLD in both men and women. Comparable cardio-metabolic risk profiles were noted between non-obese and obese NAFLD subjects. The associations of worse cardio-metabolic risk profiles with NAFLD were overall stronger in non-obese than in obese subjects among women with T2DM, while more pronounced in obese than in non-obese subjects among men with T2DM. Conclusion In patients with T2DM, non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD. The associations of metabolic disorders with NAFLD were stronger in non-obese than in obese patients in women patients with T2DM.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients
    Ziyin Zhang
    Lu Zhang
    Wangyan Jiang
    Tingting Du
    Gang Yuan
    Cardiovascular Diabetology, 21
  • [2] Non-Obese Patients With NAFLD Have More Advanced NASH Than Obese NAFLD Patients
    Danford, Christopher J.
    Sanchez, Jorge
    Choi, Yuri
    Zheng, Hui
    Misdraji, Joseph
    Masia, Ricard
    Corey, Kathleen E.
    Chung, Raymond T.
    GASTROENTEROLOGY, 2016, 150 (04) : S1144 - S1144
  • [3] A Comparison of Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) and Obese NAFLD Patients
    Mitchell, Brittany
    Aggarwal, Manik
    McCullough, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1703 - S1704
  • [4] Clinical features and risk factors associated with NAFLD in non-obese type 2 diabetes patients
    Ichikawa, Takeshi
    Oi, Itaru
    Fujino, Masayuki A.
    HEPATOLOGY, 2017, 66 : 1139A - 1139A
  • [5] Insulin Glargine is More Suitable Than Exenatide in Preventing Muscle Loss in Non-Obese Type 2 Diabetic Patients with NAFLD
    Liu, Lin
    Wang, Ruwen
    Gao, Jian
    Yan, Jianhua
    Zhang, Jingtian
    Zhang, Zhitian
    Liu, Jiaojiao
    Lin, Huandong
    Rao, Shengxiang
    Yao, Xiuzhong
    Wu, Weiyun
    Bian, Hua
    Wang, Xiangyu
    Guo, Shanshan
    Gao, Xin
    Yan, Hongmei
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (11) : 583 - 588
  • [6] Risk factors for significant fibrosis in non-obese Asian patients with NAFLD
    Jeong, Jae Yoon
    Cho, Ju-Yeon
    Kim, Jung Hee
    Cho, Yong Kyun
    Kim, Byung Ik
    Sohn, Won
    JOURNAL OF HEPATOLOGY, 2023, 78 : S637 - S637
  • [7] Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?
    Takumi Kawaguchi
    Takuji Torimura
    Journal of Gastroenterology, 2020, 55 : 363 - 364
  • [8] Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?
    Kawaguchi, Takumi
    Torimura, Takuji
    JOURNAL OF GASTROENTEROLOGY, 2020, 55 (03) : 363 - 364
  • [9] A NON-INVASIVE METHOD FOR ESTIMATING THE SEVERITY OF LIVER STEATOSIS AND THE RISK OF FIBROSIS IN NON-OBESE TYPE 2 DIABETES PATIENTS WITH NAFLD
    Mitrovic, B.
    Gluvic, Z.
    Klisic, A.
    Obradovic, M.
    Macut, D.
    Tomasevic, R.
    Isenovic, E. R.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (04) : 480 - 487
  • [10] Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Li, Yifang
    Chen, Yanzhen
    Tian, Xing
    Zhang, Shanshan
    Jiao, Jian
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 2029 - 2039